Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business
Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business
Filed under: Industry News, Markets
Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business